Turing Pharmaceuticals

13 Stories

Shkreli Once Again in Hot Water Over Pricey Drug

'Pharma Bro' sued by FTC, New York AG over Daraprim

(Newser) - Martin Shkreli's original controversy is back in the headlines. The disgraced CEO of Turing Pharmaceuticals first gained infamy back in 2015 when his company jacked the price of Daraprim, a lifesaving drug that treats the parasitic infection toxoplasmosis, by 5,000%. Then he went to prison over an unrelated...

'Pharma Bro' Martin Shkreli Is Going on Trial
'Pharma Bro' Martin Shkreli 
Is Going on Trial
THE RUNDOWN
Jun 26, 2017 4:51 AM CDT

'Pharma Bro' Martin Shkreli Is Going on Trial

His lawyers claim he's penniless

(Newser) - Martin Shkreli's federal trial on securities fraud charges begins this week—and since the former pharmaceutical boss has been dubbed "the most hated man in America," there won't be any shortage of cheerleaders for the prosecution. Shkreli, 34, is accused of illegally taking stock from Retrophin,...

Martin Shkreli Now Praising Kids Who Made Cheap Drug

He makes congratulatory video after belittling their work on Twitter

(Newser) - A bunch of Aussie schoolkids produced a $2-a-pill version of a super-expensive anti-parasitic drug ($750 per dose), and the man behind the latter drug's huge price hike is now praising their efforts, Reuters reports. In a YouTube video directed toward students at Sydney Grammar School, ex-Turing Pharmaceuticals CEO Martin...

Take That, Martin Shkreli: Schoolkids Cook Up $2 Dose

High school students show cheap version of pricey drug is easy to make

(Newser) - Remember Martin Shkreli, the hedge fund manager who last year founded Turing Pharmaceuticals, acquired an essential anti-parasitic drug, and quickly jacked up its price 55-fold, from $13.50 to $750 a pill? Well, he's just been shown up by a group of high school chemistry students in Australia who'...

Martin Shkreli Celebrates Price Hike in Newly Released Emails

'$1 bn here we come'

(Newser) - Documents and emails released Tuesday by congressional investigators show "pharma bro" and Internet villain Martin Shkreli "giddily rubbing his palms together at the prospect of all the money Daraprim will generate," as NPR puts it. Shkreli and his company, Turing Pharmaceuticals, acquired the drug Daraprim—frequently used...

Usually Chatty Martin Shkreli Takes the 5th

Pharma bad boy's tight lips 'could hinder' Senate committee's investigation

(Newser) - Martin Shkreli "loves to talk," notes the New York Times , but the ex-Turing Pharmaceuticals CEO has taken the Fifth as a Senate committee looks into drug-pricing practices—and his refusal to hand over subpoenaed documents could impede the probe, NBC News reports. "Absent a valid justification...

Pharma CEO Resigns
 Pharma CEO Resigns 
Dec 18, 2015 12:56 PM CST

Pharma CEO Resigns

Martin Shkreli leaves Turing, though he remains CEO of another firm

(Newser) - Corporate-speak at its best: "We wish to thank Martin for helping us build Turing Pharmaceuticals into the dynamic research focused company it is today, and wish him the best in his future endeavors." So reads a statement from Turing Pharmaceuticals Friday. Martin, of course, is Martin Shkreli , whose...

You Won’t Like Who Paid $2M for 'Rarest Album Ever'

It's the pharma CEO we all love to hate, Martin Shkreli

(Newser) - A mysterious buyer purchased the so-called " rarest album ever created " for a sum reportedly in the millions. Now, Bloomberg Businessweek reveals exactly who bought Wu-Tang Clan's Once Upon a Time in Shaolin, of which just one copy exists: Martin Shkreli, the "price-gouging" Turing Pharmaceuticals CEO the...

Notorious Drug CEO Wishes He Raised Price Even Higher

'This is a capitalist society,' says Martin Shkreli

(Newser) - Ah, hindsight. If he could do it all over again, what would Martin Shkreli—the CEO vilified for raising the price of a drug 5,000%—do differently? "I probably would have raised prices higher, is probably what I should have done," he said in response to a...

Notorious Drug CEO Making Enemies in Stock Market

Martin Shkreli accused of 'rampant share price manipulation'

(Newser) - The drug company CEO that everyone loves to hate is back in the news again for making enemies. This time, however, Martin Shkreli is not accused of jacking up the price of a drug. Instead, critics says he's engaged in market manipulation in the biotech industry. Or as Forbes...

Drug CEO and Internet Villain Is at It Again

Company goes back on promise to lower drug price after jacking it 5,000%

(Newser) - Former-hedge-fund-manager-turned-Internet-villain Martin Shkreli and his company, Turing Pharmaceuticals, are back in the news this week, months after raising the price of a 62-year-old drug by 5,000% and then promising to maybe not actually do that , Ars Technica reports. But it turns out Turing won't be lowering the cost...

Reviled Pharma CEO Holds Epic AMA on Reddit

Martin Shkreli says recent brouhaha over his price gouging is good for his love life

(Newser) - Perhaps trying to win back customers who are likely defecting to his new competitor , Martin Shkreli took to Reddit in an epic "Ask Me Anything" session that lasted from Saturday evening well into Sunday (with breaks), per his Twitter feed . In what TechCrunch calls "one of the most...

Infamous $750 Pill Is Undercut by $1 Alternative

Imprimis Pharmaceuticals is going after market for Shkreli's toxoplasmosis drug

(Newser) - Martin Shkreli has been hemming and hawing about dropping the price of his company's toxoplasmosis drug since he raised it 5,000% in August, but it may be a moot point: A San Diego drug compounding company is now offering its own version of pyrimethamine for $1 a pill,...

13 Stories
Most Read on Newser